FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer — FDA Drug Information Updates — Overcast

Overcast Podcaster Info Ads Log In

FDA Drug Information Updates

FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

July 28, 2017

0:00 -:--

Speed

–1×+++++2×+

Website • Share link • Share link with timestamp